To include your compound in the COVID-19 Resource Center, submit it here.
Amgen Inc. (NASDAQ:AMGN) granted Daiichi Sankyo Co. Ltd. (Tokyo:4568) exclusive rights to commercialize nine biosimilars in Japan. Amgen will remain
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury